Stocks & Investing
Thu, October 3, 2024
[ 12:00 AM ] - WOPRAI
Tue, October 1, 2024
[ 12:00 AM ] - WOPRAI
Wed, September 25, 2024
[ 12:00 AM ] - WOPRAI
Wed, September 18, 2024
[ 12:00 AM ] - WOPRAI
Mon, September 16, 2024
[ 12:00 AM ] - WOPRAI
Wed, September 11, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 14, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 13, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, August 12, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 8, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, August 6, 2024
[ 12:00 AM ] - WOPRAI
Mon, August 5, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 1, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, July 25, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, July 19, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, July 10, 2024
[ 12:00 AM ] - WOPRAI
Fri, June 28, 2024
[ 12:00 AM ] - WOPRAI
Thu, June 27, 2024
[ 12:00 AM ] - WOPRAI
Wed, June 26, 2024 Andrew Fein Reiterated (ABOS) at Strong Buy and Held Target at $15 on, Oct 3rd, 2024
Andrew Fein of HC Wainwright & Co., Reiterated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $15 on, Oct 3rd, 2024.
Andrew has made no other calls on ABOS in the last 4 months.
There are 2 other peers that have a rating on ABOS. Out of the 2 peers that are also analyzing ABOS, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $6 on, Thursday, August 15th, 2024
- David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $7 on, Thursday, July 25th, 2024
